Intimation regarding the Board''s decision to close the Company''s wholly-owned subsidiary - Fermenta Biotech (UK) Limited.

November 05, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, Dalal Street, Fort, G Block, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai 400 051 Scrip Code: 506414 Trading Symbol: FERMENTA Dear Sir, Subject: Intimation regarding the Board’s decision to close the Company’s wholly- owned subsidiary - Fermenta Biotech (UK) Limited. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we wish to inform you that the Board of Directors of the Company, at its meeting held today, has given its approval to close the Company’s wholly- owned subsidiary viz. Fermenta Biotech (UK) Limited (“FBL UK”) by way of feasible permissible modes as per the provisions of the United Kingdom Law. FBL UK is not a material subsidiary of the Company. FBL UK was acquired by the Company on September 10, 2002. However, owing to various reasons including exit of the United Kingdom from the European Union and the Company having an operational wholly-owned subsidiary in Germany viz. Fermenta Biotech GmbH to cater to the European market, there have been no operations in FBL UK for several years. As per the financials for F.Y. 2025-26, FBL UK had no turnover and had a loss of £ 1,260. Its Net assets were £ 30,231 mostly comprising cash at bank. The decision to close FBL UK is mainly in order to have better corporate structure reorganization and reduce compliance costs. The details required under Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is enclosed as Annexure A. Kindly take the above on record. Thanking you, Yours faithfully, For Fermenta Biotech Limited Varadvinayak Khambete Company Secretary & Head - Legal Membership No. A33861 Annexure A Disclosure Pursuant to Regulation 30 of SEBI LODR Regulations read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Sr. Particulars Details 1 The amount and percentage of the turnover or Turnover, revenue and income revenue or income and net worth contributed by contributed: Nil such unit or division or undertaking or subsidiary or associate company of the listed entity during the last financial year. 2 Date on which the agreement for sale has been Not Applicable. entered into. 3 The expected date of completion of sale/disposal. This cannot be ascertained; however, the timelines shall be as per the statutory provisions and procedures. 4 Consideration received from such sale/disposal. Not Applicable (as it is a closure of a wholly-owned subsidiary). 5 Brief details of buyers and whether any of the Not Applicable. buyers belong to the promoter/ promoter group/group companies. If yes, details thereof. 6 Whether the transaction would fall within related Not Applicable. party transactions? If yes, whether the same is done at “arm’s length”. 7 Whether the sale, lease or disposal of the Not Applicable. undertaking is outside Scheme of Arrangement? If yes, details of the same including compliance with regulation 37A of LODR Regulations. 8 Additionally, in case of a slump sale, indicative Not Applicable. disclosures provided for amalgamation/ merger, shall be disclosed by the listed entity with respect to such slump sale.